Clinical Trials: Lowereing A1C, Weight Change & CV Data

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

Cureus, Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes, Cardiovascular Diabetology

2021 ESC Guidelines on Cardiovascular Disease Prevention

Weight loss and benefits for cardiovascular disease (CVD)

Tirzepatide for Type 2 Diabetes and Weight Management

Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First-in-Class Twincretin

diabetes #T2DM #antidiabeticagents #oraldiabeticagents FIGURE

Next Step in Incretin-Based Therapy: From Single to Dual Agonism - European Medical Journal